相关实验视频
Updated: Sep 15, 2025

05:56
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
2.2K
在临床相关的败血症模型中,持续输注抗素III
Naoki Hayase1, Rohit R Chari, Alef A C Dos Santos
1Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.
Shock (Augusta, Ga.)
|July 15, 2025
概括
在败血症发作后持续输注抗素III (AT) 改善了小鼠的生存率. 这种延迟的,连续的AT输送效果优于玻尿酸注射,这表明了败血症的新治疗方法.
科学领域:
- 败血症的研究研究.
- 药理干预措施 药理干预
- 疾病的动物模型.
背景情况:
- 在临床前的败血症模型中,抗血素III (AT) 呈现出有希望的结果,但在临床试验中失败了.
- 侮辱类型和药物管理时间表的差异可能解释试验失败.
- 这项研究使用临床相关的多微生物败血症模型 (Cecal Ligation and Puncture,CLP) 重新评估了AT.
研究的目的:
- 在临床相关的多微生物败血症模型中研究延迟,连续的抗素III (AT) 输液的疗效.
- 为了比较连续的AT输液与传统的AT玻尿酸注射.
- 探索AT对生存,器官损伤和败血症炎症标志物的影响.
主要方法:
- 小鼠接受了结和刺穿 (CLP) 手术,以诱导多微生物性败血症.
- 奥斯摩斯迷你连续输送AT或盐水,从败血症诱导后大约6小时开始.
- 生存率和器官损伤 (肝脏,脏,肺) 分别在7天和48小时后进行评估.
主要成果:
- 延迟,连续的AT输液显著改善了7天的存活率,与液 (65%对29%) 和玻尿酸AT (65%对19%) 相比.
- 持续的AT减弱肝损伤,血管泄漏和炎症性细胞因子,与肝脏中高细菌和血栓积累相关.
- 和肺损伤没有受到AT治疗的显著影响.
结论:
- 延迟,连续的AT输液在CLP败血症模型中提高了生存率,优于玻尿酸注射.
- 由于细菌负载和血栓生成,肝脏在腹部败血症中显得至关重要,在这种情况下,AT显示出保护作用.
- 抗氧化剂的好处可能来自于减轻血栓诱导的血管泄漏和肝脏炎症;为了更广泛的器官保护,可能需要组合疗法.
相关概念视频
Venous Thrombosis III: Interprofessional Care
25
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
25
Anticoagulant Drugs: Low-Molecular-Weight Heparins
917
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
917

